Japan· JP-2499414D1031
メトレレプチン（遺伝子組換え）
A medicinal product containing メトレレプチン（遺伝子組換え）, registered in Japan by キエジ・ファーマ・ジャパン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- メトレレプチン（遺伝子組換え）
- Manufacturer
- キエジ・ファーマ・ジャパン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
メトレレプチン（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMYALEPTAChiesi Farmaceutici S.p.A., Parma
- SwedenMyalepta 11,3 mg Pulver till injektionsvätska, lösningChiesi Farmaceutici S.p.A.
- BelgiumMyalepta 11.3 mgChiesi Farmaceutici
- SpainMYALEPTA 11,3 MG POLVO PARA SOLUCION INYECTABLEChiesi Farmaceutici S.P.A.
- FinlandMyaleptaChiesi Farmaceutici S.p.A.
- FranceMYALEPTA 11,3 mg, poudre pour solution injectableCHIESI FARMACEUTICI
- United KingdomMyalepta 11.3mg powder for solution for injection vialsChiesi Ltd
- CanadaMYALEPTACHIESI FARMACEUTICI S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Myalepta
- Liechtenstein · Myalepta
- Norway · Myalepta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd360d87-d88a-436f-b865-20956c10eb2c GET /v1/drugs/dd360d87-d88a-436f-b865-20956c10eb2c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１１．２５ｍｇ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2499414D1031",
"category": "注射薬",
"price_yen": 35490,
"generic_name": "メトレレプチン（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "2499",
"transitional_expiry": null
}See everything about メトレレプチン（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.